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ABSTRACT
Method: First, the 2,4-thiazolidinedione was substituted at the position of 3 using sodium hydroxide and ethanol and then substituted at the position 
of 5 in the presence of piperdine by the Knoevenagel condensation method. The structures of the compounds were established on the basis of infrared 
and nuclear magnetic resonance spectral studies.
Result: 3,5-disubstituted-5-benzylidine-2,4-thiazolidinediones derivative was synthesized using benzyl halides and aromatic aldehydes. The results 
obtained showed that TZ-1 exhibited good activity against Bacillus subtilis while no activity against Escherichia coli.
Conclusion: Attachment of more heterocyclic rings containing Nitrogen on the 3rd position of 2,4-thiazolidinedione can enhance the antimicrobial activity. 
Addition of more lipophilic agents may increase the bioavailability and efficacy of the drug. Long alkyl chains on the benzylidene ring can also increase the 
lipophilic character, and further attachment of these kind of agents on benzylidene chain may produce safe and effective compounds in future.
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INTRODUCTION
The increasing identification of antibiotic-resistant pathogens that cause 
serious infections cannot be ignored. Although the future cannot be 
predicted with certainty, it is surely possible that an extensive epidemic 
of resistant bacterial infections could potentially harm millions of 
people. Given that it takes more than 10 years to establish the efficacy 
and safety of new compounds, there is an urgent need to restock the 
antibiotic pipeline. As various infections are the medical challenge, such 
as gastrointestinal tract GIT infections, HIV, Hepatitis C and urinary tract 
infections, and the 2,4-thiazolidinediones can be the key to the problem. 
Due to the resistance and many side effects of antibiotics being used, 
there is a need for new antimicrobials. Like penicillin has severe side 
effects, i.e., anaphylaxis and GIT disturbance, and due to acid liability 
of penicillin, it cannot be given orally. However, 2,4-thiazolidinedione 
derivatives resemble penicillin’s heterocyclic ring but has no acid 
liability and can be given orally in various infections. Hence, the valuable 
properties of 2,4-thiazolidinedione compel to synthesize its various 
derivatives by substituting at position 3 and 5 [1-4].
Why 2,4-thiazolidinedione derivative is chosen for antimicrobial 
activity.
There are some reasons because of which this nucleus is chosen for 
antimicrobial activity.
•	 2,4-thiazolidinedione	has	nitrogen	 in	 the	heterocyclic	 ring.	 It	has	
been proved that  whenever nitrogen is present as the member of 
the heterocyclic ring, it must have antimicrobial activity, for example, 
beta-lactam ring of penicillin and quinoline and isoquinoline.
•	 2,4-Thiazolidinedione	is	the	new	antimicrobial	which	will	decrease	
the chances of resistance [5,6].
Scheme of synthesis
In scheme, the formed 2,4-TZD first reacted with substituted benzyl 
halide instead of substituted benzaldehyde, and the N-substituted-2,4-
TZDs are reacted with substituted benzaldehyde, and other 2,4-TZD 
derivatives are the main products.
The synthesized compounds were then evaluated for their 
pharmacological activity. For antimicrobial activity, all compounds were 
taken and were evaluated using cup plate method against Bacillus subtilis 
and Escherichia coli. Ciprofloxacin was taken as standard and zone of 
inhibition was measured. The title compounds were synthesized by 
Knoevenagel condensation and substitution reactions. The synthesized 
compound was then evaluated for its antimicrobial activity [4,7].
© 2018 The Authors. Published by Innovare Academic Sciences Pvt Ltd. This is an open access article under the CC BY license (http://creativecommons. 
org/licenses/by/4. 0/) DOI: http://dx.doi.org/10.22159/ajpcr.2018.v11i11.12008
Research Article
Objective: 2,4-Thiazolidinedione derivatives was launched as antidiabetics in 90’s. Later the derivatives of 2,4-thiazolidinedione were banned due to 
hepatotoxicity. To the date, much research has been directed toward the synthesis and novel uses of 2,4-thiazolidinedione compounds.
The aim of the present study is to synthesize a set of 3,5-disudstituted-2,4-thiazolidinediones as antimicrobial. These compounds were evaluated for 
their antimicrobial activity.
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MATERIALS AND METHODS
Materials
1. All the chemicals used were procured from C.D.H and HiMedia and 
purified	before	use.
2. Melting points were determined on the open capillary tube on 
Campbell Melting Point Apparatus and are uncorrected.
3. The silica gel used for thin layer chromatography (TLC) was “silica gel 
G” procured from Merck and was coated on laboratory glass slides.
4. TLC plates were visualized using an iodine chamber.
5. Infrared (IR) spectra were taken using Fourier transform IR Thermo 
scientific;	NICOLET	 Is10	and	KBr	disk	 spectrophotometer.	Only	
principal peaks are reported and expressed in cm−1.
6. Proton nuclear magnetic resonance spectra (1H NMR) were recorded 
on Bruker AC 300 F, 300 MHz spectrophotometers. Chemical shifts 
are	expressed	as	δ	value	(ppm),	downfield	from	tetramethylsilane	
used as internal standard.
7. While citing 1H NMR data, the following abbreviations have been 
used S (singlet), d (doublet), t (triplet), and m (multiplet).
Methods
Drying of ethanol
Ethanol of high degree of purity is conveniently obtained by dehydrating 
commercial ethanol with calcium oxide. In 500 ml RB flask, poured the 
content of the commercially obtained ethanol, to it add 1 g of calcium oxide 
and allowed for refluxing. It was then distilled and collected for further use.
Drying of toluene
Commercial toluene may contain methyl thiophenone, which cannot be 
removed by distillation. It can be purified by treating with concentrated 
sulfuric acid, but care was taken that temperature was not allowed 
to rise unduly (<30°C) as toluene is sulfonated more easily than 
benzene and then store the dry toluene over sodium wire, phosphorus 
pentaoxide, or calcium hydride.
Drying of acetone
To the 700 ml acetone contained in a liter bottle, a solution of 3gm of 
silver nitrate in 20 ml of water as added followed by 10 ml of 1M NaOH 
solution, and the mixture was shaken for about 10 min. The mix was 
then filtered dried with calcium sulfate and distilled [7].
Experimental work [7-10]
Step 1: Synthesis of 2,4-thiazolidinedione
Procedure
In a 250 ml three-necked flask a solution containing 56.4 g 0.6 mole of 
chloroacetic acid in 60 ml of water and 45.6 g (0.6 moles) of thiourea 
dissolved in 60 ml of water. The mixture was stirred for 15 min. To 
the contents of the flask were now added slowly 60 ml concentrated 
hydrochloric acid from dropping funnel, after which the reaction 
mixture was stirred and refluxed for 10–12 h at 100–110°C. On cooling, 
the contents of the flask solidified to a mass of clusters of white needles. 
The product was filtered and washed with water to remove traces of 
hydrochloric acid and dried. It was re-crystallized from ethanol.
Yield: 85%.
Synthesis of 3-(4’chlorobenzyl)-2, 4-thiazolidinedione
Step 2: Procedure
In a 250 ml RBF, NaOH (0.8 g, 0.02 moles) was dissolved in 20 ml 
ethanol. To this solution, 2, 4-thiazolidinedione (0.02 moles) and 
benzyl bromide were (0.02 moles) added. The resulting reaction 
mixture was then refluxed for 40 h. Precipitation of salt was observed 
during the reaction. At the end of the reflux period, ethanol was 
distilled out, and the residue was extracted from ether and water. 
The ethereal layer was removed, dried over sodium sulfate and 




Synthesis of 5-benzylidene-N-substituted-2,4-thiazolidinedione 
derivatives
Synthesis of 5-(4’’hydroxy benzylidene)-3-(4’ chlorobenzyl)-2,4-
thiazolidinedione
Procedure
In a 250ml 3-necked round bottom flask provided with a Dean-
Stark apparatus, 4-hydroxy benzaldehyde (0.188 moles) and 
3-chlorobenzyl-2, 4-thiazolidinedione (0.188 moles) were together 
suspended in dry toluene. To this catalytic amount of piperidine (1ml) 
was added. The mixture was refluxed with stirring. After complete 
removal of water and when the temperature crossed 110°C the reaction 
mixture was stirred for further 1 hr. On cooling, the product precipitated 
out of toluene. The compound was filtered and washed with cold, dry 
toluene, and dry ethanol.
Yield: 72%
Melting point - 205°C.
TLC of 5-(4’’hydoxybenzylidene)-3-(4’ chlorobenzyl)-2,4-
thiazolidinedione (Table 1)
Rf value: 0.61
Table 1: Characterization data of the synthesized compound
Compound Yield (%) Melting point Rf. value
TZ-1 66 205°C 0.16
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Spectral analysis
NMR study of 5-(4’’hydoxy benzylidene)-3-(4’chlorobenzyl)-2,4-
thiazolidinedione (TZ-1)
NMR:	δ	4.89	(s,2H,CH2),	δ	7.25-7.44	(m,9H,ArH),	δ	7.83	(s,1H,OH)
IR study of 5-(4’’hydoxy benzylidene)-3-(4’chlorobenzyl)-2,4-
thiazolidinedione
IR of 5-(4’’-hydroxybenzylidene)-3-(4’chlorobenzyl)-2,4-TZD (TZ-1) 
(Table 2)
Pharmacological activity
We determined 2,4 thiazolidinedione as antimicrobial using the cup 
plate method. We found very interesting results of inhibition of the 
growth of Gram-positive as well as Gram-negative bacteria.
Pharmacological activity
Antimicrobial activity [11-13]
Various therapeutic agents which show inhibition of growth of 
microorganisms such as antibiotics or essential for their growth such as 
vitamins and amino acids are standardized by microbiological assays.
Any change in the antibiotic molecule which may not be detected by 
chemical methods will be revealed by a change in the antimicrobial 
Table 2: IR and 1HNMR data
S. No Molecule code IR (cm−1) 1H NMR (ppm)
1 TZ-1 1732.12, 1336.77, 1082.43, 3036.31, 1603.83, 1493.82, 2955.00 3.89 (s, 1H), 4.89 (s, 2H), 7.24-7.50 (s, 10H)
IR: 1723.02 cm−1 (Ketone, C=O), 1588.62 cm−1 and 1493.84 cm−1 (Aromatic C=C), 3346.16 cm−1 (Phenolic OH), 2925.35 cm−1 (Alkane, C-H), 1342.67 cm−1–
1086.80 cm−1(Amine C-N). IR: Infrared, 1H NMR: Proton nuclear magnetic resonance spectra
activity, and hence microbiological assays are very useful for resolving 
doubts regarding a possible change in potency of antibiotics.
The minimal assay is based on a comparison of the inhibition of growth 
of microorganisms by measured concentrations of the antibiotic to be 
examined with that produced by known concentrations of a standard 
preparation of the antibiotic having the known activity.
Two general methods are used for microbiological assays of antibiotics:
 Method A: Cylinder plate method or cup plate method
 Method B: Turbidimetric method or tube assay method.
The cylinder plate method depends on diffusion of the antibiotic from 
the vertical cylinder through a solidified agar layer in Petri plate to an 
extent such that growth of the added microorganisms is prevented 
entirely in a zone around the cylinder containing a solution of the 
antibiotics.
The turbidimetric method depends on the inhibition of growth of 
microbial culture in a uniform solution of antibiotic in a fluid that is 
favorable to its rapid growth in the absence of the antibiotic.
Minimum inhibitory concentration is defined as the lowest concentration 
of an antibacterial that will inhibit the visible growth of microorganisms, 
and minimum bactericidal concentration is the lowest concentration 
of antibacterial that will prevent the growth of microorganisms after 
subculture antibiotic-free media. Any compound showing inhibition 
zone exceeding 9 mm diameter and quality of zone better or comparable 
to ciprofloxacin is considered to be endowed with antibacterial potential.
Procedure
Antimicrobial activity of the synthesized 3,5-disubstituted 
thiazolidinediones derivative was carried out using cup plate method. 
The compounds were tested against stain of B. subtilis and E. coli. Stock 
solution of the synthesized compounds was prepared in dimethyl 
sulfoxide (DMSO), and the ciprofloxacin was prepared in distilled water. 
Dilution of the stock solution of synthesized compound was done using 
DMSO and 3000 µg/ml concentration was prepared in micro test tubes. 
The stock solution of standard, i.e., ciprofloxacin was diluted in sterile 
water to give a concentration of 100 µg/ml.
100 µl organism suspensions were seeded on culture plates. Then, 
in each, the agar plate cavities/well (9 mm) was prepared using a 
cork borer. 100 µl of the compound was transferred to the wells and 
ciprofloxacin (100 µg/ml) was added to the remaining well. The plates 
were incubated at 30°C. The plates were observed for growth at the end 
of 24–48 h and the zone of inhibition was measured.
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The number 5 (Fig. a and b) is the zone of inhibition shown by 
5-(4’’-hydroxybenzylidene)-3-(4’chlorobenzyl)-2,4-TZD on both Gram-
positive and Gram-negative bacteria. The no. 6 (Fig. a and b) is the zone 
of inhibition by standard drug ciprofloxacin.
A set of negative and positive controls of growth were also kept for 
incubation along with test plates. In the plate, for negative growth, the 
highest volume of DMSO and sterile distilled water was used with no 
culture being seeded, while in the plate representing maximum growth 
(positive control), the highest volume of DMSO and sterile distilled 
water was used along with the organism.
Graphical representation of antimicrobial activity
Activity against B. subtilis
Activity against E. coli (Table 3)
RESULTS
The derivative 5-(4’’-hydroxybenzylidene)-3-(4’chlorobenzyl)-
2,4-TZD (TZ-1) was found to be active against only Gram-positive 
bacteria (B. subtilis) but showed no activity against Gram-negative 
bacteria (E. coli). TZ-1 showed remarkable activity against Gram-
positive bacteria but less effective than ciprofloxacin used as 
reference drug.
SUMMARY AND DISCUSSION
3,5-disubstituted-5-benzylidine-2,4-thiazolidinediones derivative was 
synthesized using benzyl halides and aromatic aldehydes. Synthesized 
compound was characterized by chromatographic methods, IR 
spectroscopy, and NMR spectroscopy for their structural confirmation. 
This compound was tested for antimicrobial activity.
Antimicrobial evaluation of the compound was done against B. subtilis 
and E. coli using Cup Plate method. The results obtained showed that 
TZ-1 exhibited good activity against B. subtilis while no activity against 
E. coli.
CONCLUSION
Due to some disadvantages of long reaction times, use of large quantities 
of volatile organic and harsh conditions, therefore, development of an 
efficient and versatile method is still required.
The work on this project was started with the objective of synthesizing 
some known 2,4-thiazolidinedione by different methods as reported 
in literature. Further modifications on benzylidene ring and nitrogen 
of the 2,4-thiazolidinedione ring may increase antimicrobial activity. 
Attachment of more lipophilic agents may increase the bioavailability 
and efficacy of the drug.
Long alkyl chains on the benzylidene ring can also increase the 
lipophilic character, and further attachment of these kind of agents on 
benzylidene chain may produce safe and effective compounds in future.
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